NEW YORK, April 26, 2017 /PRNewswire/ --
Four equities have been lined up for review on Stock-Callers.com today, and they are: Alere Inc. (NYSE: ALR), OpGen Inc.
(NASDAQ: OPGN), Novadaq Technologies Inc. (NASDAQ: NVDQ), and PRA Health Sciences Inc. (NASDAQ: PRAH). These stocks belong to the
Medical Laboratories and Research category, which is very small from a dividend perspective. Companies in this group focus on
performing various tests on patients that give them information on the health of patients. Learn more about these stocks by
downloading their free report at:
http://stock-callers.com/registration
Alere
On Tuesday, shares in Waltham, Massachusetts headquartered Alere Inc. recorded a trading
volume of 1.60 million shares, which was above their three months average volume of 1.27 million shares. The stock ended the
session 0.16% higher at $49.12. The Company's shares have gained 25.53% in the last one month,
24.35% over the previous three months, and 26.05% on an YTD basis. The stock is trading 20.70% above its 50-day moving average
and 21.51% above its 200-day moving average. Moreover, shares of Alere, which provides professional diagnostic products and
services for infectious and cardiometabolic disease, and toxicology in the US, Europe, and
internationally, have a Relative Strength Index (RSI) of 81.07.
On April 11 th, 2017, Alere announced that its Alere™ Reader, a diagnostic
analyzer that can be used in both point-of-care and laboratory settings, has received 510(k) marketing clearance from the US Food
and Drug Administration. The Alere Reader will be initially available for use with the BinaxNOW® Influenza A & B Card 2, with
other lateral flow applications and assays to follow. The free research report on ALR is available at:
http://stock-callers.com/registration/?symbol=ALR
OpGen
Gaithersburg, Maryland headquartered OpGen Inc.'s stock closed the day 6.67% higher at
$1.12. A total volume of 352,909 shares was traded, which was above their three months average
volume of 342,830 shares. The Company's shares have advanced 4.67% in the past month. The stock is trading 4.48% above its 50-day
moving average. Additionally, shares of OpGen, which engages in developing and deploying precision medicine tools to combat
infectious disease in global healthcare settings, have an RSI of 54.22.
On April 19 th, 2017, OpGen announced that it will report its Q1 2017 financial
results after close of market on Wednesday, April 26 th, 2017. The Company's management
team will host a live conference call and webcast at 4:30 p.m. ET on the same day to discuss its
financial results and business progress. The live, listen-only webcast of the conference call may be accessed under the investors
section of the Company's website. The complimentary report on OPGN can be downloaded at:
http://stock-callers.com/registration/?symbol=OPGN
Novadaq Technologies
Shares in Mississauga, Canada headquartered Novadaq Technologies Inc. recorded a trading
volume of 320,608 shares. The stock ended yesterday's trading session 0.55% higher at $7.30. The
Company's shares have advanced 9.28% in the previous three months and 2.96% on an YTD basis. The stock is trading below its
50-day moving average by 1.46%. Furthermore, shares of Novadaq Technologies, which develops, manufactures, and markets
fluorescence imaging products for use by surgeons in the operating room and other clinical settings in the US and
internationally, have an RSI of 43.39.
On April 19 th, 2017, Novadaq Technologies announced that it will release financial
results for Q1 2017 after the close of trading on Wednesday, May 03 rd, 2017. The
Company's management team will host a corresponding conference call beginning at 4:30 p.m. ET on
the same day. A live and archived webcast of the event will be available under the "Investor Relations" section of the Company's
website. Visit us today and download our complete research report on NVDQ for free at:
http://stock-callers.com/registration/?symbol=NVDQ
PRA Health
Raleigh, North Carolina headquartered PRA Health Sciences Inc.'s stock finished Tuesday's
session 0.18% higher at $65.41. A total volume of 1.22 million shares was traded, which was above
their three months average volume of 491,050 shares. The Company's shares have advanced 5.93% in the last one month, 20.15% over
the previous three months, and 18.67% since the start of this year. The stock is trading above its 50-day and 200-day moving
averages by 6.03% and 18.38%, respectively. Additionally, shares of PRA Health Sciences, which provides outsourced clinical
development services to the biotechnology and pharmaceutical industries worldwide, have an RSI of 63.93.
On April 17 th, 2017, PRA Health Sciences announced that it will host its Q1 2017
conference call on Wednesday, April 26 th, 2017, at 9:00 a.m.
ET to discuss the results and guidance with members of the investment community. A live audio broadcast will be available
under the investor relations section of the Company's website. Get free access to your technical report on PRAH at:
http://stock-callers.com/registration/?symbol=PRAH
--
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES :
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a
third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on
analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed
any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently
reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or
interfere in the application of such procedures by the third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or
the Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing
of the information, or (2) warrant any results from use of the information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities
mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers
in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you ' re
a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between
09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA